Search

Roche Holding AG

Cerrado

SectorSalud

278.6 -0.14

Resumen

Variación precio

24h

Actual

Mínimo

273.4

Máximo

280

Métricas clave

By Trading Economics

Ingresos

6.3B

Ventas

31B

P/B

Media del Sector

26.169

57.333

Rentabilidad por dividendo

3.6

Margen de beneficio

20.347

Empleados

103,249

EBITDA

11B

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.60%

2.63%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

205B

Apertura anterior

278.74

Cierre anterior

278.6

Roche Holding AG Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 abr 2025, 07:30 UTC

Ganancias

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 abr 2025, 05:31 UTC

Ganancias

Roche Sales Rise Boosted By Key Drugs

9 abr 2025, 09:39 UTC

Principales Movimientos del Mercado

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mar 2025, 09:23 UTC

Principales Movimientos del Mercado

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 ene 2025, 09:36 UTC

Ganancias

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 ene 2025, 06:32 UTC

Ganancias

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

24 abr 2025, 09:39 UTC

Charlas de Mercado
Ganancias

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 abr 2025, 09:24 UTC

Charlas de Mercado
Ganancias

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 abr 2025, 09:18 UTC

Charlas de Mercado
Ganancias

Roche's Results Are Solid -- Market Talk

24 abr 2025, 05:16 UTC

Principales Noticias

Roche Sales Rise, Boosted By Key Drugs

22 abr 2025, 10:51 UTC

Principales Noticias

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 abr 2025, 09:55 UTC

Charlas de Mercado

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 abr 2025, 10:03 UTC

Charlas de Mercado
Ganancias

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 abr 2025, 07:23 UTC

Charlas de Mercado

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 abr 2025, 08:41 UTC

Charlas de Mercado

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 abr 2025, 07:51 UTC

Charlas de Mercado

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mar 2025, 09:31 UTC

Acciones populares

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mar 2025, 07:46 UTC

Charlas de Mercado

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mar 2025, 16:34 UTC

Principales Noticias

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mar 2025, 08:51 UTC

Charlas de Mercado

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mar 2025, 08:18 UTC

Charlas de Mercado

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 feb 2025, 11:43 UTC

Charlas de Mercado

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 ene 2025, 07:56 UTC

Charlas de Mercado
Ganancias

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 ene 2025, 06:04 UTC

Ganancias

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 ene 2025, 06:04 UTC

Ganancias

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 ene 2025, 06:04 UTC

Ganancias

Roche Issues 2025 View

30 ene 2025, 06:03 UTC

Ganancias

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 ene 2025, 06:03 UTC

Ganancias

Roche 2024 Core Operating Profit CHF20.82B

30 ene 2025, 06:03 UTC

Ganancias

Roche 2024 Net Pft CHF9.19B

30 ene 2025, 06:02 UTC

Ganancias

Analysts Saw 2024 Core EPS at CHF18.59

Roche Holding AG Esperado

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.